Insider · CIK 0001314596

Katkin Keith

CIK 0001314596 Name as filed on the most recent filing

Filed as Katkin Keith (30)

67 transaction lines · from 30 filings · filed 2006-05-25 to 2026-05-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

67 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-04-30 S, Open-market sale Emergent BioSolutions Inc.EBS 128,183, disposed Open Form 4 filing 0001314596-26-000002
2025-05-23 S, Open-market sale Emergent BioSolutions Inc.EBS 49,417, disposed Open Form 4 filing 0001367644-25-000136
2025-05-19 P, Open-market purchase Syndax Pharmaceuticals IncSNDX 91,120, acquired Open Form 4 filing 0000950170-25-074289
2022-10-06 S, Open-market sale Syndax Pharmaceuticals IncSNDX 2 lines 774,411, disposed Open Form 4 filing 0001562180-22-007125
2022-10-04 S, Open-market sale Syndax Pharmaceuticals IncSNDX 2 lines 9,000, disposed Open Form 4 filing 0001562180-22-007011
2022-10-03 S, Open-market sale Syndax Pharmaceuticals IncSNDX 2 lines 4,500, disposed Open Form 4 filing 0001562180-22-007011
2022-09-30 S, Open-market sale Syndax Pharmaceuticals IncSNDX 2 lines 89,277, disposed Open Form 4 filing 0001562180-22-007011
2019-12-09 S, Open-market sale Urovant Sciences Ltd.UROV 1,533,600, disposed Open Form 4 filing 0000899243-19-028937
2014-12-17 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 1,058,464, disposed Open Form 4 filing 0001209191-14-076513
2014-12-15 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 2 lines 3,646,962, disposed Open Form 4 filing 0001209191-14-076513
2014-10-24 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 324,188, disposed Open Form 4 filing 0001209191-14-064837
2014-08-01 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 50,864, disposed Open Form 4 filing 0001209191-14-050025
2014-05-28 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 2,215,482, disposed Open Form 4 filing 0001209191-14-038147
2013-12-18 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 78,935, disposed Open Form 4 filing 0001209191-13-058257
2013-11-01 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 18,138, disposed Open Form 4 filing 0001209191-13-050887
2013-08-02 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 74,981, disposed Open Form 4 filing 0001209191-13-039085
2013-05-15 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 2 lines 816,313, disposed Open Form 4 filing 0001209191-13-027421
2012-12-03 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 46,457, disposed Open Form 4 filing 0001209191-12-055926
2012-06-25 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 664,791, disposed Open Form 4 filing 0001209191-12-035538
2012-03-06 P, Open-market purchase Avanir Pharmaceuticals, Inc.AVNR 26,093, acquired Open Form 4 filing 0001209191-12-016315
2011-12-02 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 41,421, disposed Open Form 4 filing 0001209191-11-059754
2011-11-17 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 282,657, disposed Open Form 4 filing 0001209191-11-057247
2011-11-16 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 282,300, disposed Open Form 4 filing 0001209191-11-057247
2010-12-02 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 797,254, disposed Open Form 4 filing 0001209191-10-058457
2010-11-01 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 114,000, disposed Open Form 4 filing 0001209191-10-052763
2010-09-01 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 177,864, disposed Open Form 4 filing 0001209191-10-044888
2010-08-31 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 114,512, disposed Open Form 4 filing 0001209191-10-044888
2010-05-03 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 201,376, disposed Open Form 4 filing 0001209191-10-025235
2010-04-30 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 132,372, disposed Open Form 4 filing 0001209191-10-025235
2010-04-08 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 30,100, disposed Open Form 4 filing 0001209191-10-021805
2010-03-29 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 78,000, disposed Open Form 4 filing 0001209191-10-019452
2010-01-05 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 7 lines 29,276, disposed Open Form 4 filing 0001209191-10-002754
2010-01-05 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 11,766, disposed Open Form 4 filing 0001209191-10-001534
2010-01-05 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 5,985, disposed Open Form 4 filing 0001209191-10-001534
2010-01-05 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 3,921, disposed Open Form 4 filing 0001209191-10-001534
2010-01-05 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 3,880, disposed Open Form 4 filing 0001209191-10-001534
2010-01-05 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 1,785, disposed Open Form 4 filing 0001209191-10-001534
2010-01-05 S, Open-market sale Avanir Pharmaceuticals, Inc.AVNR 1,746, disposed Open Form 4 filing 0001209191-10-001534

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 6
  • Open-market sale 61
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Katkin Keith, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001314596

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.